Article Per Year (5 Year)
p-Index From 2021 - 2026
5.138
P-Index
This Author published in this journals
All Journal Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Natural Science: Journal of Science and Technology LINK Indonesian Journal of Pharmaceutical Science and Technology Biocelebes The Indonesian Journal of Public Health Berkala Kedokteran JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) As-syifaa Jurnal Farmasi Acta Pharmaciae Indonesia : Acta Pharm Indo Majalah Farmaseutik Jurnal Farmasi Indonesia Jurnal Farmasi Higea Jurnal Kefarmasian AKFARINDO PREPOTIF : Jurnal Kesehatan Masyarakat Jurnal Insan Farmasi Indonesia Journal of Health Community Service Media Publikasi Promosi Kesehatan Indonesia (MPPKI) Jurnal Pengabdian Kesehatan Masyarakat Healthy Tadulako Journal (Jurnal Kesehatan Tadulako) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Journal of Health and Nutrition Research Jurnal Pengabdian Farmasi dan Sains Jurnal Farmasi Galenika Journal of Pharmascience
Muhamad Rinaldhi Tandah
Department Of Pharmacy, Faculty Of Mathematics And Natural Sciences, Tadulako University, Indonesia
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Dentistry Education Environmental Science Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Physics Public Health Social Sciences Veterinary Other

Published : 42 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 42 Documents
Search

 1   2   3   4   5 
DAYA HAMBAT INFUSA DAUN SAWO (MANILKARA ZAPOTA L.) TERHADAP BAKTERI ESCHERICHIA COLI Tandah, Muhamad Rinaldhi; Ibrahim, Nurlina; Diana, Khusnul; Ramdhani, Wirda Suci
Natural Science: Journal of Science and Technology Vol 4, No 2 (2015): Volume 4 Number 2 (August 2015)
Publisher : Univ. Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Penelitian ini bertujuan untuk mengetahui daya hambat infusa daun sawo (Manilkara zapota L.) dalam menghambat pertumbuhan bakteri Escherichia coli sebagai penyebab penyakit diare. Metode ekstraksi yang digunakan yaitu metode infudasi, dengan konsentrasi 25%, 50% dan 75% infusa daun sawo, aquadest sebagai kontrol negatif, dan kloramfenikol sebagai kontrol positif. Dilakukan replikasi sebanyak tiga kali pada setiap kelompok perlakuan. Metode pengujian daya hambat infusa daun sawo menggunakan sumuran pada media yang telah ditanam bakteri. Hasil penelitian menunjukan adanya zona hambat selama 24 jam dan tidak ditemukan zona hambat selama 2x24 jam pada ekstrak daun sawo. Hasil analisa menunjukkan bahwa rata-rata zona hambat yang dihasilkan secara berurutan pada konsentrasi 25%, 50%, dan 75% adalah 14,66 mm, 16,30 mm, dan 19,93 mm. Pada kontrol negatif tidak terbentuk zona hambat, sedangkan  pada kontrol positif rata-rata zona hambat sebesar 38,41 mm. Kesimpulan diperoleh bahwa ekstrak daun sawo dapat menghambat E. coli dengan KHM ekstrak daun sawo pada konsentrasi 25%, namun tidak dapat membunuh E. coli karena tidak ditemukan KBM ekstrak daun sawo terhadap bakteri E. coli.
PELAKSANAAN STANDAR PELAYANAN KEFARMASIAN DI APOTEK KOTA PALU Diana, Khusnul; Tandah, Muhamad Rinaldhi; Basuki, Muhamad
Jurnal Ilmiah As-Syifaa Vol 11, No 1 (2019): AS-SYIFAA Jurnal Farmasi
Publisher : Fakultas Farmasi UMI

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (386.586 KB) | DOI: 10.33096/jifa.v11i1.504

Abstract

 The standard of pharmaceutical service is a benchmark or guideline for parmacist in carrying out pharmaceutical service in pharmacy facilities, one of them is pharmacy, in order to realize optimal health in the community. This study aims to describe the implementation of standard pharmaceutical services at the pharmacy in Palu city. This study was an observational study with descriptive qualitative data, data collection was cross sectional with the total number of samples are 56 respondents pharmacists / pharmacy in Palu city. Data was collected using questionnaire sheets distributed to respondents. From the results of the study, the standard clinical pharmacy services performed by pharmacists in the form of prescription study activities (61.6%), dispensing (36.9%), counseling (52.5%). The standard of drug management, medical devices and medical disposable carried out by pharmacist (54.3%). Clinical service standards that were not implemented at the pharmacy in the form of drug information services (62.1%), monitoring drug therapy (78.3%) and monitoring drug side effects (89.9%).
DAYA HAMBAT DEKOKTA KULIT BUAH MANGGIS (Garcinia mangostana L.) TERHADAP BAKTERI ESCHERICHIA COLI Rinaldhi Tandah, Muhamad
Healthy Tadulako Journal (Jurnal Kesehatan Tadulako) Vol. 2 No. 1 (2016)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (235.513 KB) | DOI: 10.22487/htj.v2i1.17

Abstract

Penelitian ini bertujuan untuk mengetahui zona hambat dekokta daun buah manggis (Garciniamangostana L.) dalam menghambat pertumbuhan bakteri Escherichia coli yang bisa menyebabkansariawan dalam mulut dan vagina. Metode ekstraksi yang digunakan yaitu metode dekokta, dengankonsentrasi 25%, 50% dan 75% dekokta daun buah manggis, aquadest sebagai kontrol negatif, dankotrimoksazol sebagai kontrol positif. Dilakukan replikasi sebanyak tiga kali setiap kelompok perlakuan.Metode pengujian daya hambat dekokta daun buah manggis menggunakan metode kertas cakram, dimanatiap konsentrasi dekokta daun buah manggis diserap oleh kertas cakram khusus pengujian zona hambat.Penelitian ini menunjukan bahwa selama 24 jam ditemukan zona hambat secara berurutan padakonsentrasi 25%, 50%, dan 75% adalah 3,3 mm, 5,8 mm, dan 7 mm. Pada kontrol negatif tidak terbentukzona hambat, sedangkan pada kontrol positif rata-rata zona hambat sebesar 5,5 mm. Diperoleh bahwaekstrak daun buah manggis dapat menghambat Escherichia coli dengan KHM ekstrak daun buah manggispada konsentrasi 25%.
ANALISIS KEPUASAN PELAYANAN OBAT PADA PASIEN DI PUSKESMAS BERSTANDAR ISO 9001:2008 DI DONGGALA KECAMATAN BANAWA Sri Ayu Noviyanti; Alwiyah Mukaddas; Muhamad Rinaldhi Tandah
As-Syifaa Jurnal Farmasi Vol 9, No 2 (2017): AS-SYIFAA Jurnal Farmasi
Publisher : Fakultas Farmasi UMI

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (174.857 KB) | DOI: 10.33096/jifa.v9i2.260

Abstract

Community health center is technical implementation unit of a district / municipality health service who are responsible for organizing health development in a working area. The aims of this study is to determine the relationship between drug services with the level of patient satisfaction at the pharmacy unit of Donggala community health center in Banawa subdistrict, and also to know the level of  patient satisfaction and expectations by measuring with Importance Performance Analysis method to the five dimensions of service in the pharmacy unit at Donggala community health center of Banawa subdistrict. This research was conducted at the pharmacy unit of Donggala community health center in Banawa subdistrict on September 2016 until December 2016 by purposive sampling using questionnaire as instrument through Likert scale. Patient satisfaction are measured using 5 dimension of service which are tangible, relibility, responsiveness, assurance and empathy were analyzed by Importance Performance Analysis (IPA). As the result with 151 respondents at the average of gap (GAP) is -0.82 and 80.87% match rate and the most widely indicator were mapped by cartesius diagram is in quadrant A which are the quality service must still be considered and improved. This is also shows patient in Donggala community health center are still less satisfied and their expectation are still below.
COST EVALUATION OF STROKE THERAPY COMPARED TO INA-CBGs ON INPATIENTS AT ANUTAPURA HOSPITAL Muhamad Rinaldhi Tandah; Alwiyah Mukaddas; Dewi Angriani; Gaby Nathania Angela Mangoting
The Indonesian Journal of Public Health Vol. 16 No. 2 (2021): THE INDONESIAN JOURNAL OF PUBLIC HEALTH
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (401.456 KB) | DOI: 10.20473/ijph.v16i2.2021.285-296

Abstract

ABSTRACTStroke is the third cause of death in the world after heart disease, cancer, and disability including disability categorized based on its severity: mild (I), moderate (II), and severe (III) severity. This study aims to determine the difference total cost of ischemic and hemorrhagic stroke therapy, each, with INA-CBGs rates. The method of data collection was conducted retrospectively taken from medical record data, and on patient medical expenses. The subject were ischemic and hemorrhagic stroke patients hospitalized from 2016-2017 at Anutapura Hospital who met the inclusion and exclusion criteria. There were 134 patients who met the inclusion criteria, 68% were ischemic stroke patients and 32% were hemorrhagic stroke patients. The result of research showed that there were significant differences in costs (p <0.05) between hospital real costs and INA-CBGs rates. The average total real cost of treatment for ischemic stroke therapy was IDR 7,360,196.70 and the cost of the INA-CBGs was IDR 7,427,251.65 for 91 inpatients; and the average total cost of patients with hemorrhagic stroke therapy took IDR 10,606,834.34 with average of INA CBG’s rate at IDR 4,399,393.02 for 43 inpatients. The conclusion is both of stroke therapy proved significant difference compared to BPJS claimed amount of money.Keywords: pharmacoeconomic, cost analysis, ischemic stroke, haemorrhage stroke, INA-CBG’s rate.
COST OF ILLNESS FOR CHRONIC KIDNEY DISEASE TREATMENT WITH HEMODIALYSIS IN YOGYAKARTA Ingenida Hadning; Muhammad Heyqal Wirakarsa; Muhamad Rinaldhi Tandah Tandah
Berkala Kedokteran Vol 18, No 1 (2022)
Publisher : Fakultas Kedokteran Universitas Lambung Mangkurat

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (299.631 KB) | DOI: 10.20527/jbk.v18i1.12818

Abstract

Abstract: The increase in the number of chronic kidney disease (CKD) sufferers and the expensive financing of this disease, the economic burden borne will certainly increase. This study aimed to determine the cost of illness of CKD patients undergoing hemodialysis, as well as to find out the comparison of real costs with INA-CBG’s rates. This was a pharmacoeconomic research, used the cost of illness method according to a societal perspective. The study was conducted in a type B government hospitals in Yogyakarta from January to March 2020. The population in this study were all CKD patients undergoing hemodialysis in need to mention the hospital at first. The research instruments were medical records, hospital financial data, and patient interviews. The complete data were analyzed statistically with the descriptive method and the Mann Whitney test. The number of samples was 65 patients. The results revealed the average cost of illness was 6,224,277.00 IDR for one month of treatment. The cost component that dominates was hemodialysis rate. The average real cost was 836,686 IDR for one procedure. It can be concluded that the average real cost of CKD patients with hemodialysis in the type B government hospital were significantly smaller than the INA-CBG’s rate.Keywords: Chronic Kidney Disease; Hemodialysis; Cost Of Illness; INA-CBG’s Rate 
Evaluasi Penggunaan Obat Berdasarkan Indikator Peresepan dan Pelayanan Pasien di Rumah Sakit Tora Belo Khusnul Diana; Aviva Kumala; Nina Nurlin; Muhamad Rinaldhi Tandah
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 7 No. 1SI (2020): Special Issue: Seminar Inovasi Teknologi dan Digitalisasi pada Pelayanan Kefa
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v7i1SI2020.13-19

Abstract

Pendahuluan: Praktik kefarmasian merupakan kegiatan terpadu untuk mengidentifikasi, mencegah serta menyelesaikan masalah yang berkaitan dengan obat dan kesehatan untuk  meningkatkan penggunaan  obat  yang rasional. Tujuan: Untuk mengevaluasi penggunaan obat berdasarkan indikator peresepan yang ditulis oleh dokter dan pelayanan pasien di RSUD Tora Belo, Kabupaten Sigi. Metode: Penelitian dilakukan secara retrospektif dan prospektif. Indikator peresepan digunakan untuk menghitung rata-rata jumlah obat, obat generik, antibiotik, suntik dan obat esensial/obat formularium rumah sakit yang tertera pada setiap lembar resep. Sampel resep diambil dari resep pasien umum rawat sebanyak 391 lembar dengan teknik purposive sampling, sedangkan indikator pelayanan pasien diambil dari pasien rawat jalan sebanyak 269 pasien dengan teknik accidental sampling. Hasil: Rata-rata penggunaan obat tiap lembar resep adalah 3,1 (standar: 1,8 - 2,2); persentase obat generik adalah 74,89% (standar: 81 - 94 %); persentase obat antibiotik adalah 45,52% (standar: ≤ 30%); persentase obat injeksi adalah 6,90% (standar: 0,2 - 48%); dan persentase kesesuaian obat dengan formularium rumah sakit adalah 99,17% (standar: 86 - 88%). Sedangkan dari indikator pelayanan pasien diperoleh rata-rata waktu konsultasi 4,32 menit (standar: 2,3 - 3,5 menit); rata-rata dispensing time obat non racikan 11, 42 dan racikan 22,54 menit; persentase obat yang diberikan 94,54% (standar: 100%); persentase kelengkapan label obat sebesar 100%; dan persentase pengetahuan pasien tentang penggunaan dosis yang tepat 48,12% (standar: 100%). Kesimpulan: Penggunaan obat belum memenuhi standar WHO jika dilihat dari indikator peresepan, namun masih memenuhi standar WHO jika dilihat dari indicator pelayanan.
ANALISIS BIAYA PENGOBATAN PENYAKIT GINJAL KRONIK RAWAT INAP DENGAN HEMODIALISIS DI RUMAH SAKIT UMUM DAERAH UNDATA PALU Muhamad Rinaldhi Tandah; Ihwan Ihwan; Khusnul Diana; Zulfiah Zulfiah; Nurul Ambianti
Jurnal LINK Vol 15, No 2 (2019): NOVEMBER 2019
Publisher : Pusat Penelitian dan Pengabdian kepada Masyarakat, Poltekkes Kemenkes Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (196.006 KB) | DOI: 10.31983/link.v15i2.5222

Abstract

Penyakit Ginjal Kronik (PGK) merupakan masalah kesehatan global. Pembiayaan penyakit ginjal merupakan peringkat kedua terbesar dari BPJS kesehatan setelah penyakit jantung. Indonesia memasuki era Jaminan Kesehatan Nasional (JKN) sejak 01 Januari 2014. Pola pembayaran JKN adalah dengan sistem Indonesia Case Base Group (INA-CBGs). Penelitian ini bertujuan untuk mengetahui rata-rata biaya pengobatan, komponen biaya yang paling besar, serta selisih antara biaya pengobatan pasien PGK dengan JKN rawat inap terapi hemodialisis dengan standar tarif INA-CBGs. Penelitian ini merupakan penelitian deskriptif dengan pengumpulan data sekunder berupa biaya medik langsung dari perspektif rumah sakit pada pasien PGK rawat inap dengan JKN terapi hemodialisis di RSUD Undata Palu periode Januari - Desember 2017. Hasil penelitian menunjukan rata-rata biaya medik langsung pasien PGK rawat inap dengan hemodialisis sebesar Rp 11.074.834. Komponen biaya terbesar adalah biaya hemodialisis sebesar Rp 155.122.000  (37,86%) dari total pembayaran, dan selisih antara biaya medik langsung pasien PGK JKN rawat inap hemodialisis dengan standar tarif INA-CBGs sebesar Rp 191.920.841 (46,84 %) dari total biaya rumah sakit.
FORMULASI GEL EKSTRAK PATIKAN KEBO (Euphorbia hirta L.) DAN UJI AKTIVITAS TERHADAP BAKTERI Staphylococcus epidermidis Tri Novrianti Djanggola; Yusriadi Yusriadi; Muhamad Rinaldhi Tandah
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 2 No. 2 (2016): (October 2016)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (166.065 KB) | DOI: 10.22487/j24428744.2016.v2.i2.5954

Abstract

Patikan kebo (Euphorbia hirta L.) is a plant that have activity of inhibiting the Staphylococcus epidermidis bacteria, which was known as the cause of acnes. Flavonoids and tannin as antibacterial compounds which supposedly can act as an active antiacne. Purposes of this research is formulating extract gel of patikan kebo and antibacterial activity against Staphylococcus epidermidis by agar difussion method using paper disc and to know stability of the gel. The result was analyzed by One Way ANOVA with confidence level of 95%, followed by Duncan test. The result of this research showed test antibacterial activity that difference among the concentration extract has a noticeable difference zone of inhibition and extract gel of patikan kebo not have good physical quality during 28 days of storage. Keywords: Patikan kebo (Euphorbia hirta L.), gel, antibacterial, Staphylococcus epidermidis
PROFIL KANDUNGAN KIMIA DAN AKTIVITAS ANTIBAKTERI EKSTRAK METANOL DAUN BAMBAN (Donax canniformis (G. Forst.) K. Schum.) TERHADAP Staphylococcus aureus Hidayatullah Hidayatullah; Syariful Anam; Muhamad Rinaldhi Tandah
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 1 No. 2 (2015): (October 2015)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (442.187 KB) | DOI: 10.22487/j24428744.2015.v1.i2.7899

Abstract

Bamban (Donax canniformis (G. Forst.) K. Schum.) is one of the family Marantaceae plant that has many uses such as traditional medicine. Methanol extract of bamban leaves contains phenolic, tannins and saponins compounds. The purpose of this research is to determine the class of compounds that has antibacterial activity against Staphylococcus aureus and determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) methanol extract of bamban leaves. This extract was prepared using maceration method with methanol solvent. Determination the class of compounds was initiated by bioautografi test in order to determine spots which has have antibacterial activity. Subsequently, the spot were identified the class of compound using reagent spray FeCl3 and H2SO4 10%. The determination of MIC and MBC using dilution method. Research showed there are three compounds that had antibacterial activity. These compounds were predicted as spot I and spot II which were phenolic compounds and spot III as a saponin compound. MIC and MBC value of the methanol extract of leaves bamban leaves 8% and 13%, respectively.
Co-Authors Abdul Rahman Razak Adisaputra, Arya Dibyo Afriani Kusumawati Agustinus Widodo Almira Azahriantika Alwiyah Mukaddas Alwiyah Mukaddas amelia rumi, amelia Anggraeni Agus Apriyanti Anastasia Arizah Maulidyah Arya Dibyo Adisaputra Arya Dibyo Adisaputra Ashrawini Omar Aulia, Raiza Aviva Kumala Azizah, Vina Miftahul Balqis, Ratu Basuki, Muhamad Chindy Bestari Rataba Christin Agnes Mega Diwayani Deviani Widnesari Dewi Angriani Dibyo, Arya Ekasandra, Nur Fadhilah Zainal, Setiawati Faradilla, Nadila Fatimah Azzahrah Firdawat Amir Parumpu Firdawati Amir Parumpu Gaby Nathania Angela Mangoting Handoko Putro Hardani, Muhammad Fakhrul Hidayat, Chairunisah Hidayatullah Hidayatullah Ihwam Ihwan Ihwan Ihwan Ingenida Hadning Jamaluddin Katriani, Yan Yan Khusnul Diana Kristiono, Oviani Mallisa, Twulyenna Muhammad Heyqal Wirakarsa Muzna Muzna Nadila Faradilla Ni Luh Yeni Safitri Nina Nurlin Nur Ikhlas Nurhafifah Wulandari Kassa Nurlina Ibrahim Nurul Ambianti Putri, Meliani Putri, Yenita Kartika Ratu Balqis Rhaudatul Janna, Rischa Ririen Hardani Ririen Hardani Sarlina Sarlina Setiawati Fadhilah Zainal Setiawati Fadillah Shella Monica Siti Atika Sri Ayu Noviyanti Syarif Permana Salingkat Syariful Anam Tri Novrianti Djanggola Wirda Suci Ramdhani, Wirda Suci Yuliet Yuliet Yusriadi Yusriadi Zulfiah Zulfiah